HUP9901244A3 - 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds - Google Patents

3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds

Info

Publication number: HUP9901244A3
Authority: HU; Hungary
Prior art keywords: intermediates; compounds; preparation; pharmaceutical compositions; compositions containing
Prior art date: 1995-12-08

Application number

HU9901244A

Other languages

English (en)

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-08

Filing date

1996-12-06

Publication date

2000-12-28

1996-12-06 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

1999-08-30 Publication of HUP9901244A2 publication Critical patent/HUP9901244A2/hu

2000-12-28 Publication of HUP9901244A3 publication Critical patent/HUP9901244A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HU9901244A 1995-12-08 1996-12-06 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds HUP9901244A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9514547A FR2742148B1 (fr)	1995-12-08	1995-12-08	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number	Publication Date
HUP9901244A2 HUP9901244A2 (hu)	1999-08-30
HUP9901244A3 true HUP9901244A3 (en)	2000-12-28

Family

ID=9485291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9901244A HUP9901244A3 (en)	1995-12-08	1996-12-06	3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds

Country Status (34)

Country	Link
US (1)	US5925768A (hu)
EP (2)	EP0868420B1 (hu)
JP (1)	JP3510270B2 (hu)
KR (1)	KR100488610B1 (hu)
CN (1)	CN1101813C (hu)
AR (1)	AR004364A1 (hu)
AT (1)	ATE191211T1 (hu)
AU (1)	AU718763B2 (hu)
BR (1)	BR9611986A (hu)
CA (1)	CA2239489C (hu)
CZ (1)	CZ294307B6 (hu)
DE (1)	DE69607484T2 (hu)
DK (1)	DK0868420T3 (hu)
EE (1)	EE04674B1 (hu)
ES (1)	ES2148820T3 (hu)
FR (1)	FR2742148B1 (hu)
GR (1)	GR3033626T3 (hu)
HU (1)	HUP9901244A3 (hu)
IL (1)	IL124801A (hu)
IS (1)	IS4765A (hu)
MX (1)	MX9804565A (hu)
MY (1)	MY115228A (hu)
NO (1)	NO310683B1 (hu)
NZ (1)	NZ323962A (hu)
PL (1)	PL186466B1 (hu)
PT (1)	PT868420E (hu)
RU (1)	RU2170230C2 (hu)
SI (1)	SI0868420T1 (hu)
SK (1)	SK283706B6 (hu)
TR (1)	TR199801041T2 (hu)
TW (1)	TW402594B (hu)
UA (1)	UA44913C2 (hu)
WO (1)	WO1997021682A1 (hu)
ZA (1)	ZA9610299B (hu)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2283797A1 (en) *	1997-03-18	1998-09-24	Paul Elliot Bender	Novel cannabinoid receptor agonists
EP1075470B1 (en) *	1998-05-04	2003-08-13	The University Of Connecticut	Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en) *	1998-06-09	2009-09-15	University Of Connecticut	Inhibitors of the anandamide transporter
US7897598B2 (en) *	1998-06-09	2011-03-01	Alexandros Makriyannis	Inhibitors of the anandamide transporter
US7161016B1 (en)	1998-11-24	2007-01-09	University Of Connecticut	Cannabimimetic lipid amides as useful medications
US7276613B1 (en)	1998-11-24	2007-10-02	University Of Connecticut	Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US6566560B2 (en)	1999-03-22	2003-05-20	Immugen Pharmaceuticals, Inc.	Resorcinolic compounds
HUP0203437A3 (en)	1999-03-22	2003-07-28	Immugen Pharmaceuticals Inc So	Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
US7741365B2 (en) *	1999-10-18	2010-06-22	University Of Connecticut	Peripheral cannabinoid receptor (CB2) selective ligands
WO2003020217A2 (en) *	2001-08-31	2003-03-13	University Of Connecticut	Novel pyrazole analogs acting on cannabinoid receptors
MXPA02005103A (es)	1999-10-18	2003-09-25	Alexipharma Inc	Ligandos selectivos del receptor de canabinoide (cb2) perifericos.
US7393842B2 (en) *	2001-08-31	2008-07-01	University Of Connecticut	Pyrazole analogs acting on cannabinoid receptors
CA2387892A1 (en) *	1999-10-18	2001-04-26	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US7119108B1 (en) *	1999-10-18	2006-10-10	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) *	1999-10-18	2005-09-13	University Of Connecticut	Bicyclic cannabinoid agonists for the cannabinoid receptor
US8084467B2 (en) *	1999-10-18	2011-12-27	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en)	1999-10-18	2005-05-31	University Of Connecticut	Cannabimimetic indole derivatives
FR2800372B1 (fr) *	1999-11-03	2001-12-07	Sanofi Synthelabo	Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
WO2002026224A2 (en) *	2000-09-28	2002-04-04	Immugen Pharmaceuticals, Inc.	Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) *	2000-09-28	2002-04-08	Immugen Pharmaceuticals, Inc.	Antiviral methods and compounds
US8449908B2 (en)	2000-12-22	2013-05-28	Alltranz, Llc	Transdermal delivery of cannabidiol
CA2435409A1 (en) *	2001-01-26	2002-08-01	University Of Connecticut	Novel cannabimimetic ligands
ATE478670T1 (de)	2001-01-29	2010-09-15	Univ Connecticut	Rezeptor-selektive cannabimimetische aminoalkylindole
US7067539B2 (en) *	2001-02-08	2006-06-27	Schering Corporation	Cannabinoid receptor ligands
US7507767B2 (en) *	2001-02-08	2009-03-24	Schering Corporation	Cannabinoid receptor ligands
AU2002320430A1 (en) *	2001-07-13	2003-01-29	University Of Connecticut	Novel bicyclic and tricyclic cannabinoids
WO2003007887A2 (en) *	2001-07-20	2003-01-30	Merck & Co., Inc.	Substituted imidazoles as cannabinoid receptor modulators
CN1589269A (zh) *	2001-10-26	2005-03-02	康涅狄格大学	杂1,2－二氢化茚:一类新型有效的大麻配体
NZ532291A (en) *	2001-11-14	2005-11-25	Schering Corp	Cannabinoid receptor ligands
US20040171613A1 (en) *	2001-12-27	2004-09-02	Japan Tobacco Inc.	Therapeutic agent for non-immediate type allergic diseases
WO2003061699A1 (fr) *	2001-12-27	2003-07-31	Japan Tobacco, Inc.	Remedes pour affections allergiques
WO2003075917A1 (en)	2002-03-08	2003-09-18	Signal Pharmaceuticals, Inc.	Combination therapy for treating, preventing or managing proliferative disorders and cancers
AU2003214226A1 (en) *	2002-03-18	2003-10-08	Immugen Pharmaceuticals, Inc.	Topical formulations of resorcinols and cannibinoids and methods of use
US6825209B2 (en)	2002-04-15	2004-11-30	Research Triangle Institute	Compounds having unique CB1 receptor binding selectivity and methods for their production and use
DE60319714T2 (de)	2002-06-19	2009-04-02	Schering Corp.	Agonisten des cannabinoidrezeptors
US6972291B2 (en) *	2002-07-02	2005-12-06	Bernstein Richard K	Method for reducing food intake
UY27939A1 (es) *	2002-08-21	2004-03-31	Glaxo Group Ltd	Compuestos
AU2003260436A1 (en) *	2002-08-21	2004-03-11	Glaxo Group Limited	Pyrimidine compounds
JP2006511460A (ja)	2002-08-23	2006-04-06	ユニバーシティオブコネチカット	治療適応を持つケトカンナビノイド
GB0222495D0 (en) *	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
GB0222493D0 (en) *	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
US7765162B2 (en) *	2002-10-07	2010-07-27	Mastercard International Incorporated	Method and system for conducting off-line and on-line pre-authorized payment transactions
CA2502511A1 (en) *	2002-10-18	2004-05-29	Pfizer Products Inc.	Cannabinoid receptor ligands and uses thereof
US7129239B2 (en) *	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
MXPA05005512A (es)	2002-11-25	2005-07-25	Schering Corp	Ligandos receptores canabinoides.
US7247628B2 (en) *	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
EP1606019A1 (en) *	2003-03-07	2005-12-21	The University Court of The University of Aberdeen	Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
AR043633A1 (es) *	2003-03-20	2005-08-03	Schering Corp	Ligandos de receptores de canabinoides
US20040214856A1 (en) *	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) *	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) *	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
EP1622876A1 (en) *	2003-05-07	2006-02-08	Pfizer Products Inc.	Cannabinoid receptor ligands and uses thereof
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US20040259887A1 (en) *	2003-06-18	2004-12-23	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
FR2856683A1 (fr) *	2003-06-25	2004-12-31	Sanofi Synthelabo	Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
GB0402355D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
GB0402356D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
GB0402357D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
JP2007523207A (ja) *	2004-02-23	2007-08-16	グラクソ　グループ　リミテッド	カンナビノイド受容体モジュレーターとしてのピリミジン誘導体
DE602005009500D1 (de) *	2004-02-24	2008-10-16	Glaxo Group Ltd	Pyridinderivate und deren verwendung als modulatoren des cb2-rezeptors
ITMI20041032A1 (it) *	2004-05-24	2004-08-24	Neuroscienze S C A R L	Compositi farmaceutici
EP1768667B1 (en) *	2004-06-22	2009-09-30	Schering Corporation	Cannabinoid receptor ligands
WO2006025069A2 (en)	2004-07-12	2006-03-09	Cadila Healthcare Limited	Tricyclic pyrazole derivatives as cannabinoid receptor modulators
US20060025448A1 (en)	2004-07-22	2006-02-02	Cadila Healthcare Limited	Hair growth stimulators
FR2875230A1 (fr) *	2004-09-13	2006-03-17	Sanofi Aventis Sa	Derives de pyrazole condense, leur preparation et leur application en therapeutique
CN101111494A (zh) *	2004-11-29	2008-01-23	沃纳-兰伯特有限公司	具有治疗作用的吡唑并[3,4-b]吡啶和吲唑
EP1845972A4 (en) *	2005-01-10	2010-12-22	Univ Connecticut	CANNAPINOID RECEPTORS APPLYING NOVEL HETEROPYRROL ANALOGS
US8853205B2 (en)	2005-01-10	2014-10-07	University Of Connecticut	Heteropyrrole analogs acting on cannabinoid receptors
FR2887550A1 (fr) *	2005-06-24	2006-12-29	Sanofi Aventis Sa	Derives de 1-benzylpyrazole-3-acetamide, leur preparation et leur application en therapeutique
US7687481B2 (en) *	2006-03-10	2010-03-30	Jenrin Discovery, Inc.	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
WO2007121687A1 (fr) *	2006-04-26	2007-11-01	Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China	Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments
AU2007245733A1 (en) *	2006-04-27	2007-11-08	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising CBX cannabinoid receptor modulators and Potassium channel modulators
US20070254863A1 (en) *	2006-04-27	2007-11-01	Jochen Antel	Use of CBx cannabinoid receptor modulators as potassium channel modulators
US7763607B2 (en) *	2006-04-27	2010-07-27	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
US7875647B2 (en) *	2006-09-29	2011-01-25	Green Cross Corporation	Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
CN103145620A (zh)	2006-12-18	2013-06-12	7Tm制药联合股份有限公司	Cb1受体调节剂
GB0702862D0 (en) *	2007-02-14	2007-03-28	Univ Aberdeen	Therapeutic compounds
EP1985295A1 (en)	2007-04-04	2008-10-29	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
CN101314591B (zh) *	2007-05-30	2010-09-29	上海阳帆医药科技有限公司	吡唑类高选择性大麻受体-1拮抗剂和/或反向激动剂
FR2916758B1 (fr) *	2007-06-04	2009-10-09	Sanofi Aventis Sa	Derives de 1-benzylpyrazole, leur preparation et leur application en therapeutique
CA2694325C (en) *	2007-07-30	2015-09-22	Alltranz Inc.	Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
US8367714B2 (en) *	2007-08-28	2013-02-05	Vanderbilt University	Cannabinoid receptor targeted agent
US8133904B2 (en) *	2007-09-07	2012-03-13	Jenrin Discovery, Inc.	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
KR20100072037A (ko) *	2007-09-20	2010-06-29	애보트 헬스케어 프로덕츠 비.브이.	칸나비노이드 ｃｂ₁수용체 효능제로서의 5-아릴-4,5-디하이드로-(1ｈ)-피라졸
US20090247619A1 (en) *	2008-03-06	2009-10-01	University Of Kentucky	Cannabinoid-Containing Compositions and Methods for Their Use
US10053444B2 (en)	2009-02-19	2018-08-21	University Of Connecticut	Cannabinergic nitrate esters and related analogs
EP2311443A1 (en)	2009-10-15	2011-04-20	Rheinische Friedrich-Wilhelms-Universität	Pharmaceutical composition containing cannabinoid-receptor 2 antagonists
CN102329192A (zh) *	2011-09-30	2012-01-25	山东天一化学股份有限公司	溴化苄的合成方法
PE20170664A1 (es) *	2014-06-06	2017-06-10	Res Triangle Inst	Agonistas del receptor de apelina(apj) y usos de los mismos
EP3942934A1 (en)	2015-06-12	2022-01-26	Vettore, LLC	Mct4 inhibitors for treating disease
CA3046212A1 (en)	2016-12-12	2018-06-21	Vettore, LLC	Heterocyclic inhibitors of mct4
US10420089B2 (en)	2017-08-10	2019-09-17	At&T Intellectual Property I, L.P.	Adaptive two-stage downlink control channel structure for code block group based fifth generation (5G) or other next generation systems
CA3125847A1 (en)	2020-07-27	2022-01-27	Makscientific, Llc	Process for making biologically active compounds and intermediates thereof
US12054480B2 (en)	2020-07-31	2024-08-06	Makscientific, Llc	Compounds for treating cannabinoid toxicity and acute cannabinoid overdose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015651A (en) *	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
FR2665898B1 (fr) *	1990-08-20	1994-03-11	Sanofi	Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2714057B1 (fr) *	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.

1995
- 1995-12-08 FR FR9514547A patent/FR2742148B1/fr not_active Expired - Fee Related
1996
- 1996-12-06 PL PL96327177A patent/PL186466B1/pl not_active IP Right Cessation
- 1996-12-06 EE EE9800171A patent/EE04674B1/xx not_active IP Right Cessation
- 1996-12-06 ZA ZA9610299A patent/ZA9610299B/xx unknown
- 1996-12-06 EP EP96941716A patent/EP0868420B1/fr not_active Expired - Lifetime
- 1996-12-06 US US09/077,767 patent/US5925768A/en not_active Expired - Lifetime
- 1996-12-06 AT AT96941716T patent/ATE191211T1/de not_active IP Right Cessation
- 1996-12-06 AU AU11010/97A patent/AU718763B2/en not_active Ceased
- 1996-12-06 HU HU9901244A patent/HUP9901244A3/hu unknown
- 1996-12-06 CA CA002239489A patent/CA2239489C/en not_active Expired - Fee Related
- 1996-12-06 NZ NZ323962A patent/NZ323962A/xx not_active IP Right Cessation
- 1996-12-06 KR KR10-1998-0704296A patent/KR100488610B1/ko not_active IP Right Cessation
- 1996-12-06 EP EP98401565A patent/EP0885889A3/fr not_active Withdrawn
- 1996-12-06 UA UA98062944A patent/UA44913C2/uk unknown
- 1996-12-06 BR BR9611986A patent/BR9611986A/pt not_active IP Right Cessation
- 1996-12-06 DE DE69607484T patent/DE69607484T2/de not_active Expired - Lifetime
- 1996-12-06 WO PCT/FR1996/001953 patent/WO1997021682A1/fr active IP Right Grant
- 1996-12-06 DK DK96941716T patent/DK0868420T3/da active
- 1996-12-06 TR TR1998/01041T patent/TR199801041T2/xx unknown
- 1996-12-06 JP JP52178697A patent/JP3510270B2/ja not_active Expired - Fee Related
- 1996-12-06 CN CN96199643A patent/CN1101813C/zh not_active Expired - Fee Related
- 1996-12-06 PT PT96941716T patent/PT868420E/pt unknown
- 1996-12-06 RU RU98112606/04A patent/RU2170230C2/ru not_active IP Right Cessation
- 1996-12-06 AR ARP960105525A patent/AR004364A1/es active IP Right Grant
- 1996-12-06 CZ CZ19981775A patent/CZ294307B6/cs not_active IP Right Cessation
- 1996-12-06 SI SI9630209T patent/SI0868420T1/xx unknown
- 1996-12-06 ES ES96941716T patent/ES2148820T3/es not_active Expired - Lifetime
- 1996-12-06 SK SK758-98A patent/SK283706B6/sk not_active IP Right Cessation
- 1996-12-06 IL IL12480196A patent/IL124801A/en not_active IP Right Cessation
- 1996-12-07 TW TW085115150A patent/TW402594B/zh active
- 1996-12-07 MY MYPI96005160A patent/MY115228A/en unknown
1998
- 1998-06-05 NO NO19982589A patent/NO310683B1/no not_active IP Right Cessation
- 1998-06-08 IS IS4765A patent/IS4765A/is unknown
- 1998-06-08 MX MX9804565A patent/MX9804565A/es not_active IP Right Cessation
2000
- 2000-06-07 GR GR20000401312T patent/GR3033626T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2000502080A (ja)	2000-02-22
GR3033626T3 (en)	2000-10-31
NO982589L (no)	1998-08-03
EP0868420A1 (fr)	1998-10-07
ES2148820T3 (es)	2000-10-16
CA2239489C (en)	2006-05-09
UA44913C2 (uk)	2002-03-15
CN1207731A (zh)	1999-02-10
JP3510270B2 (ja)	2004-03-22
PL186466B1 (pl)	2004-01-30
MY115228A (en)	2003-04-30
WO1997021682A1 (fr)	1997-06-19
BR9611986A (pt)	1999-02-17
EE04674B1 (et)	2006-08-15
EP0885889A3 (fr)	1999-01-27
IL124801A0 (en)	1999-01-26
TW402594B (en)	2000-08-21
US5925768A (en)	1999-07-20
EP0885889A2 (fr)	1998-12-23
IS4765A (is)	1998-06-08
NO310683B1 (no)	2001-08-13
SK75898A3 (en)	1999-01-11
CA2239489A1 (en)	1997-06-19
TR199801041T2 (xx)	1998-08-21
PL327177A1 (en)	1998-11-23
DE69607484D1 (de)	2000-05-04
CZ177598A3 (cs)	1998-10-14
CN1101813C (zh)	2003-02-19
IL124801A (en)	2004-07-25
AU718763B2 (en)	2000-04-20
ATE191211T1 (de)	2000-04-15
KR19990072004A (ko)	1999-09-27
AR004364A1 (es)	1998-11-04
DE69607484T2 (de)	2000-10-26
EE9800171A (et)	1998-12-15
AU1101097A (en)	1997-07-03
MX9804565A (es)	1998-09-30
FR2742148A1 (fr)	1997-06-13
FR2742148B1 (fr)	1999-10-22
SI0868420T1 (en)	2000-10-31
PT868420E (pt)	2000-08-31
HUP9901244A2 (hu)	1999-08-30
CZ294307B6 (cs)	2004-11-10
KR100488610B1 (ko)	2005-09-26
EP0868420B1 (fr)	2000-03-29
DK0868420T3 (da)	2000-08-21
ZA9610299B (en)	1997-06-18
NZ323962A (en)	1999-05-28
NO982589D0 (no)	1998-06-05
RU2170230C2 (ru)	2001-07-10
SK283706B6 (sk)	2003-12-02

Publication	Publication Date	Title
HUP9901244A3 (en)	2000-12-28	3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9701169A3 (en)	1999-07-28	Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9901159A3 (en)	2000-05-29	Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP9702409A3 (en)	1999-06-28	1,4,5-trisubstituted imidazole derivatives useful as cytokine, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9901243A3 (en)	2001-11-28	Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9801556A3 (en)	1998-11-30	Phenylpyridazinone -derivatives, intermediates, preparation and use thereof and herbicide compositions containing these compounds
HUP9700709A3 (en)	2000-04-28	1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
NZ304901A (en)	1998-12-23	Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0002869A3 (en)	2003-01-28	Benzothiophenecarboxamide derivatives, pharmaceutical compositions thereof and intermediates
HUP9901037A3 (en)	2001-11-28	Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9700328A3 (en)	1998-09-28	Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
HUP0102307A3 (en)	2002-02-28	Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP9900617A3 (en)	2001-12-28	Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds
HUP9901184A3 (en)	2001-11-28	Antibacterial benzoxazine and pyrido-oxazine derivatives, intermediates, pharmaceutical compositions containing these compounds, preparation and use thereof
HUP9900975A3 (en)	2001-12-28	Quinoxalinedione derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9901096A3 (en)	2000-12-28	Indole derivatives, preparation and use thereof, pharmaceutical composition containing these compounds
SI0918059T1 (en)	2003-12-31	Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
HUP9701194A3 (en)	1999-06-28	4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9902454A3 (en)	2002-01-28	Substituted 1,2,3,4-tetrahydronaphthalene derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
IL118426A0 (en)	1996-09-12	Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
HUP0002272A3 (en)	2002-03-28	Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
IL116746A0 (en)	1996-05-14	Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
IL112589A (en)	2000-06-01	Polysubstituted-3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives process and novel intermediates for their preparation and pharmaceutical compositions containing them
HUP9801386A3 (en)	2000-03-28	Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
HUP9900865A3 (en)	2000-02-28	Anti-viral benzimidazole derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds

Legal Events

Date	Code	Title	Description
2011-09-28	FD9A	Lapse of provisional protection due to non-payment of fees